Publications: Dr Charlotte Lindsay
Lindsay C, Davenport R, Baksaas-Aasen K, Kolstadbråten KM, Naess PA, Curry N, Maegele M, Juffermans N et al.
(
2024
)
.
Correction of Trauma-induced Coagulopathy by Goal-directed Therapy: A Secondary Analysis of the ITACTIC Trial
.
Anesthesiology
vol.
141
,
(
5
)
904
-
912
.
Lindsay C, Green L, Henry J, O’Halloran PJ, Davenport R
(
2024
)
.
Coagulopathy and Prophylaxis of Venous Thromboembolism in Traumatic Brain Injury
.
Traumatic Brain Injury
,
Springer Nature
Schofield H, Lindsay C, Brohi K, Davenport R
(
2023
)
.
Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock
.
Journal of Thrombosis and Haemostasis
vol.
22
,
(
3
)
676
-
685
.
Hannadjas I, James A, Davenport R, Lindsay C, Brohi K, Cole E
(
2023
)
.
Prothrombin complex concentrate (PCC) for treatment of trauma-induced coagulopathy: systematic review and meta-analyses
.
Critical Care
vol.
27
,
(
1
)
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H et al.
(
2023
)
.
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
401
,
(
10387
)
1499
-
1507
.
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H et al.
(
2022
)
.
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
.
The Lancet
vol.
400
,
(
10349
)
359
-
368
.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al.
(
2022
)
.
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
399
,
(
10325
)
665
-
676
.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al.
(
2021
)
.
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
399
,
(
10320
)
143
-
151
.
Group RC
(
2021
)
.
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet Respiratory Medicine
vol.
9
,
(
12
)
1419
-
1426
.
Cottey L, Roberts T, Graham B, Horner D, Latour JM, Enki D, Lyttle MD, Stevens KN
(
2021
)
.
Need for recovery and physician well-being in emergency departments: national survey findings
.
European Journal of Emergency Medicine
vol.
28
,
(
5
)
386
-
393
.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al.
(
2021
)
.
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
.
The Lancet
vol.
397
,
(
10289
)
2049
-
2059
.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al.
(
2021
)
.
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
397
,
(
10285
)
1637
-
1645
.
Cottey L, Roberts T, Graham B, Horner D, Stevens KN, Enki D, Lyttle MD, Latour J et al.
(
2020
)
.
Need for recovery amongst emergency physicians in the UK and Ireland: a cross-sectional survey
.
BMJ Open
vol.
10
,
(
11
)